|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
43.120 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 1,097,002 | 1,150,438 | 1,133,551 | 1,162,719 | 892,374 |
| Net Cash from / (used in) Investing Activities | (4,739,122) | (1,534,225) | (2,565,410) | (2,521,608) | (2,231,312) |
| Net Cash from / (used in) Financing Activities | (1,702,410) | (7,806) | 809,249 | (163,093) | 9,339,458 |
| Increase / (Decrease) in Cash & Cash Equivalents | (5,344,531) | (391,593) | (622,610) | (1,521,982) | 8,000,520 |
| Cash & Cash Equivalents at beginning of period | 7,399,941 | 7,782,741 | 8,378,417 | 9,959,963 | 2,006,926 |
| Effect of Foreign Exchange Rate Changes | (6,917) | 8,793 | 26,934 | (59,564) | (47,483) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 2,048,494 | 7,399,941 | 7,782,741 | 8,378,417 | 9,959,963 |
| Remarks: | Real time quote last updated: 30/10/2025 08:28 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 383,337 |
| %Change | -22.220% |
| EPS / (LPS) | RMB 0.450 |
| NBV Per Share (¥) | RMB 24.001 |